The Physician-Patient Alliance for Health & Safety (PPAHS) announced its intention to develop a position statement on recommendations for procedural sedation.
Michael Wong, JD (Founder and Executive Director, PPAHS) explained that such a position statement on recommendations for procedural sedation would encapsulate guidelines and recommendations from leading medical organizations in Canada and the United States:
The IHI/NPSF Patient Safety Congress, taking place from May 23-25, 2018, in Boston, MA, brings together people who are passionate about ensuring safe care equitably for all across the globe. This annual meeting is the must-attend event for committed health care professionals who continue to shape smarter, safer care for patients wherever it’s provided – from the hospitalized to outpatient settings to the home.
The Physician-Patient Alliance for Health & Safety (PPAHS) is very pleased to announce that Marilyn Neder Flack, who was the Senior Vice President, Patient Safety Initiatives at the Association for the Advancement of Medical Instrumentation (AAMI) and Executive Director at the AAMI Foundation, has been appointed to PPAHS’s board of advisors.
During her tenure at AAMI, Ms. Flack’s spearheaded key patient safety initiatives, including clinical alarm management, continuous electronic monitoring of patients on opioids, home healthcare technology, safe infusion therapy safety, and the safe use of complex health technology.
The Physician-Patient Alliance for Health & Safety released a clinical education podcast – Selecting Patient Monitoring Systems.
“We are often asked by our clinical followers what patient monitoring systems that we would recommend,” said Michael Wong, JD (Founder/Executives Director). “To help with their decision making process, we have produced a clinical education podcast to provide some guidance on selecting patient monitoring devices.”
The Physician-Patient Alliance for Health & Safety (PPAHS) announced its intention to broaden its discussion of respiratory compromise to include non-opioid-related issues and COPD’s role in respiratory compromise.
Michael Wong, JD (Founder and Executive Director, PPAHS) explained that a discussion of COPD’s role in respiratory compromise is a natural progression of PPAHS initiative in growing awareness of this critical patient safety issue:
In a clinical education podcast, Frank Overdyk, MD, who is an anesthesiologist practicing in Charleston, SC, discusses preventing avoidable deaths and the costs of monitoring patients receiving opioids and the costs of not being monitored. It is impossible to predict with 100% accuracy how a particular patient will react when administered an opioid. Continuous patient monitoring, which costs just $20-$30 per day in the case of monitoring with pulse oximetry, is a small price to pay to help prevent avoidable patient deaths.
By Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety)
I recently interviewed Frank Overdyk, MD, who is an anesthesiologist practicing in Charleston, SC, about the costs of monitoring patients receiving opioids and the costs of not being monitored. Dr. Overdyk is a member of board of advisors of the Physician-Patient Alliance for Health & Safety and organized the two conferences on opioid-induced respiratory depression (“OIRD”) for the Anesthesia Patient Safety Foundation.